Read this Press Release to see the exciting news on the label change of Focused Ultrasound (ExAblate).

The FDA has now approved physicians to treat 100% of the fibroid. “In allowing doctors to destroy the entire fibroid, we believe the FDA has demonstrated further confidence in the safety and efficacy of the non-invasive ExAblate system,” said Haywood L. Brown, MD, Chair of Obstetrics and Gynecology/Maternal-Fetal Medicine at Duke Medicine in Durham, North Carolina.”

Although Focused Ultrasound is still not FDA approved for women who still seek to become pregnant, there are encouraging statistics noted at the end of this press release that indicate that this treatment still allows for women to to become pregnant after this procedure. “To date, InSightec has reported 54 pregnancies, 22 deliveries with 11 ongoing pregnancies with women who previously underwent the ExAblate procedure.”

Clinical studies are still being done on women who wish to have children. For more information please see our clinical trials page.